This repository of patient-derived cancer mouse models used to probe the mechanisms of cancer, advance drug discovery, test new anti-cancer compounds, and create innovative therapeutic strategies.
The Meyer Cancer Center’s shared resources represent state-of-the-art support services and technology that provide critical support to investigators. Additional technologies are available via Weill Cornell’s core facilities.
The Epigenomics Core Facility provides DNA methylation profiling, protein-nucleic acid association (ChIP-Seq), genome sequencing, exome capture, RNA-seq and bioinformatics analysis.
The Genomics Resources Core Facility provides state-of-the-art services in high through-put genomics technologies, including experimental design, sample manipulation, instrumentation, data analysis, interpretation and validation.
Through a shared facility with the Hospital for Special Surgery and an on-site service at the Department of Pathology & Laboratory Medicine, members have access to flow cytometers, scanners, cell sorters, and full test services.
Protein identification and quantitation, post-translational modification analysis, MS data analysis, RapidFire high throughput sequencing, and targeted & untargeted analysis of metabolites, drugs and other small molecules.